Literature DB >> 24757618

LBBB: State-of-the-Art Criteria.

Mohammad Hosein Nikoo1, Amir Aslani1, Mohammad Vahid Jorat1.   

Abstract

Entities:  

Keywords:  Criteria; Left Bundle Branch Block

Year:  2013        PMID: 24757618      PMCID: PMC3987432     

Source DB:  PubMed          Journal:  Int Cardiovasc Res J        ISSN: 2251-9130


× No keyword cloud information.
We started diagnosing Bundle Branch Block about 100 years ago on dog models (1). However, about 40 years passed until we could diagnose Left Bundle Branch Block (LBBB) correctly on ECG (2). Today, we have conventional criteria for diagnosing LBBB, including QRS duration>120 msec, QS or rS in lead V1, Monophasic R wave with no Q wave in lead V6 and I3, ACC/AHA/HRS added notched R wave in lead I,aVL, V5, and V6, and occasional RS pattern in V5 and V6 (3). In case rate dependent LBBB develops, you can see the disappearance of the q wave in V6, then initial slurring of R wave and delayed increased intrinsicoid deflection. More complete LBBB causes notched plateau after initial peaked R wave (4). LBB has anterior fascicle, posterior fascicle, and sometimes a septal fascicle (5). Blocking the left bundle may cause septal force to disappear; therefore, no initial R wave can be detected in V1 or Q wave in I, V5, and V6, but that is not always the case (5). Sometimes, septal MI causes initial Q in the lateral leads and initial R wave in V1. Also, Grants and Doge found initial septal force in 40% of their cases with LBBB (6). Accordingly, initial septal force should not be considered as a diagnostic criterion for LBBB. Widening of QRS may occur in LBBB as well as many other conditions, such as LVH, RVH, and IVCD. Sometimes, LBBB also causes minimally increased width in QRS named incomplete LBBB. Wilson compared dogs and humans and suggested 120 msec. as the cut-off point for diagnosing LBB (2); however, this may need revision based on the findings of the study by Selvester and Salmon (7). They showed that when LBB is blocked, 40 msec. are required for septal depolarization, then 50 msec to reach the posterolateral wall, and finally 50 msec to complete posterolateral wall activations. Moreover, they suggested 140 msec. for males and 130 msec. for females for diagnosis of LBBB. The most consistent finding in LBBB patients seems to be mid QRS notching or slurring which is best seen in I, aVl, V5, and V6 (3). This mid QRS notching shows two vectors that are in the relatively same direction but one is minimally delayed. The first vector shows depolarization of endocardium of the left ventricle, while the second one seem to show depolarization of epicardium of the posterolateral wall (8). Diagnosis of LBBB using ECG may be accompanied by some errors as high as 30 % of cases. Therefore, LBBB is better to be confirmed through intracardiac mapping techniques. However, only a limited number of studies have investigated the issue. Josephson nicely mapped about 40 patients and his consistent finding was nearly 40-msec delay between RV endocardium and LV endocardium in LBBB patients (9). Furthermore, Vassallo et al. showed that only ⅔ of the LBBB patient diagnosed on ECG had more than 40 msec. trans-septal activation on intracardiac mapping; thus, the accuracy of the routine criteria for diagnosis of LBBB was only 70% (10). In 2004, Auricchio performed 3-dimensional contact and noncontact mapping for LBBB patient and his results showed the same accuracy as the conventional ECG criteria (11). All these lead us to wrong diagnosis of LBBB in ⅓ of our patients and this is the exact number of non-responders in CRT patients where diagnosis of LBBB is a pre- requisites (12). Considering what was mentioned above, new criteria for LBBB are needed and the best suggestions include: QRS more than 140 msec for males and 130 msec for females Notching of peak QRS in at least two leads from I,avL, V1, V2, V5, and V6 QS or rS in lead V1 (13). This new definition can be used for picking up the cases of CRT implantation and the patients follow up may solve the mystery of non-responders in CRT patients.
  8 in total

1.  Mechanisms of QRS complex prolongation in man; left ventricular conduction disturbances.

Authors:  R P GRANT; H T DODGE
Journal:  Am J Med       Date:  1956-06       Impact factor: 4.965

Review 2.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology.

Authors:  Borys Surawicz; Rory Childers; Barbara J Deal; Leonard S Gettes; James J Bailey; Anton Gorgels; E William Hancock; Mark Josephson; Paul Kligfield; Jan A Kors; Peter Macfarlane; Jay W Mason; David M Mirvis; Peter Okin; Olle Pahlm; Pentti M Rautaharju; Gerard van Herpen; Galen S Wagner; Hein Wellens
Journal:  J Am Coll Cardiol       Date:  2009-03-17       Impact factor: 24.094

Review 3.  The QRS complex--a biomarker that "images" the heart: QRS scores to quantify myocardial scar in the presence of normal and abnormal ventricular conduction.

Authors:  David G Strauss; Ronald H Selvester
Journal:  J Electrocardiol       Date:  2008-09-13       Impact factor: 1.438

4.  Left ventricular endocardial activation during right ventricular pacing: effect of underlying heart disease.

Authors:  J A Vassallo; D M Cassidy; J M Miller; A E Buxton; F E Marchlinski; M E Josephson
Journal:  J Am Coll Cardiol       Date:  1986-06       Impact factor: 24.094

5.  Incomplete left bundle-branch block. A definite electrocardiographic entity.

Authors:  S S Barold; J W Linhart; F J Hildner; O S Narula; P Samet
Journal:  Circulation       Date:  1968-10       Impact factor: 29.690

6.  Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

Authors:  Wojciech Zareba; Helmut Klein; Iwona Cygankiewicz; W Jackson Hall; Scott McNitt; Mary Brown; David Cannom; James P Daubert; Michael Eldar; Michael R Gold; Jeffrey J Goldberger; Ilan Goldenberg; Edgar Lichstein; Heinz Pitschner; Mayer Rashtian; Scott Solomon; Sami Viskin; Paul Wang; Arthur J Moss
Journal:  Circulation       Date:  2011-02-28       Impact factor: 29.690

Review 7.  Defining left bundle branch block in the era of cardiac resynchronization therapy.

Authors:  David G Strauss; Ronald H Selvester; Galen S Wagner
Journal:  Am J Cardiol       Date:  2011-03-15       Impact factor: 2.778

8.  Characterization of left ventricular activation in patients with heart failure and left bundle-branch block.

Authors:  Angelo Auricchio; Cecilia Fantoni; Francois Regoli; Corrado Carbucicchio; Andreas Goette; Christoph Geller; Michael Kloss; Helmut Klein
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

  8 in total
  3 in total

1.  Validation of an automatic diagnosis of strict left bundle branch block criteria using 12-lead electrocardiograms.

Authors:  Xiaojuan Xia; Anne-Christine Ruwald; Martin H Ruwald; Nene Ugoeke; Barbara Szepietowska; Valentina Kutyifa; Mehmet K Aktas; Poul Erik B Thomsen; Wojciech Zareba; Arthur J Moss; Jean-Philippe Couderc
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-08-30       Impact factor: 1.468

Review 2.  Optimizing Cardiac Resynchronization Therapy: an Update on New Insights and Advancements.

Authors:  Adam Grimaldi; Eiran Z Gorodeski; John Rickard
Journal:  Curr Heart Fail Rep       Date:  2018-06

Review 3.  Prevention of non-response to cardiac resynchronization therapy: points to remember.

Authors:  Huolan Zhu; Tong Zou; You Zhong; Chenguang Yang; Yirong Ren; Fang Wang
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.